Assessing the risks of haemolysis as an adverse reaction following the transfusion of ABO incompatible plasma-containing components – A scoping review

Published year

2022

Authors

McCullagh J, Cardigan R, Brunskill SJ, Bullock T, Doree C, Estcourt L, et al

Abstract

PubMed

Full text (subscription may be required)

Elsevier

Additional Information

Blood Reviews. 2022;56:100989.

Page last reviewed:
Next review date: